Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2020

01-12-2020 | Metastasis | ASO Author Reflections

ASO Author Reflections: Is Breast Cancer Dissemination Lymphatic, Hematogenous, or Both; and Does It Matter?

Author: S. David Nathanson, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2020

Login to get access

Excerpt

The evolution of surgical management of carcinomas of major organs in the early twentieth century depended upon the belief that cancers of ectodermal and endodermal origin metastasized to regional lymph nodes (RLNs). Halsted1 extrapolated this belief to the treatment of breast cancer (BC), showing that surgical removal of the entire organ (the breast) plus the RLNs and the intervening pectoralis muscles in one piece resulted in long-term cure in about a third of cases, suggesting that systemic metastasis (smets) could sometimes be averted. In the absence of adjuvant systemic and radiation therapy during those years this also meant that direct invasion into the bloodstream probably had not occurred in those patients and that the primary route of smets was through the RLNs. Surgical cure alone was possible. This persuasive conclusion was used by other surgeons to justify the concept of surgical resection of organs such as the stomach, pancreas, rectum, colon, uterus, prostate, and lung together with RLNs in one piece. …
Literature
1.
go back to reference Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46(1):1–19.CrossRef Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46(1):1–19.CrossRef
2.
go back to reference Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRef Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–75.CrossRef
3.
go back to reference Fisher B. Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnovsky memorial lecture. Cancer Res. 1980;40(11):3863–74.PubMed Fisher B. Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnovsky memorial lecture. Cancer Res. 1980;40(11):3863–74.PubMed
4.
go back to reference Folkman J. Proceedings: tumor angiogenesis factor. Cancer Res. 1974;34(8):2109–13.PubMed Folkman J. Proceedings: tumor angiogenesis factor. Cancer Res. 1974;34(8):2109–13.PubMed
5.
go back to reference Nathanson SD, Leonard-Murali S, Burmeister C, Susick L, Baker P. Clinico-pathological evaluation of the potential anatomic pathways of systemic metastasis from primary breast cancer suggests an orderly spread through the regional lymph nodes. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08904-w. Nathanson SD, Leonard-Murali S, Burmeister C, Susick L, Baker P. Clinico-pathological evaluation of the potential anatomic pathways of systemic metastasis from primary breast cancer suggests an orderly spread through the regional lymph nodes. Ann Surg Oncol. 2020. https://​doi.​org/​10.​1245/​s10434-020-08904-w.
Metadata
Title
ASO Author Reflections: Is Breast Cancer Dissemination Lymphatic, Hematogenous, or Both; and Does It Matter?
Author
S. David Nathanson, MD
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08932-6

Other articles of this Special Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue